July 28 (Reuters) – Lepu Biopharma Co Ltd: * REPORTS POSITIVE TOP-LINE RESULTS FROM GLOBAL PHASE III TRIAL OF CMG901 (AZD0901) Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Brazil's Bolsonaro is barred from this year's election. Can his AI avatar campaign instead?
By Ricardo Brito and Luciana Magalhaes BRASILIA/SAO PAULO, July 28 (Reuters) - Former Brazilian President…
Birkin bag maker Hermes delivers modest sales improvement
By Dominique Patton PARIS, July 29 (Reuters) - Hermes reported a slight acceleration in growth…
Hewitt's son Cruz earns first ATP Tour win in Washington opener
VIDEO SHOWS: HIGHLIGHTS OF OPENING ROUND OF MUBADALA DC OPEN IN WASHINGTON - MATCH POINT…
